These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The anaplerotic node is essential for the intracellular survival of Basu P; Sandhu N; Bhatt A; Singh A; Balhana R; Gobe I; Crowhurst NA; Mendum TA; Gao L; Ward JL; Beale MH; McFadden J; Beste DJV J Biol Chem; 2018 Apr; 293(15):5695-5704. PubMed ID: 29475946 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach. Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808 [TBL] [Abstract][Full Text] [Related]
6. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488 [TBL] [Abstract][Full Text] [Related]
7. Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets. Shaku M; Ealand C; Kana BD Front Cell Infect Microbiol; 2020; 10():603382. PubMed ID: 33282752 [No Abstract] [Full Text] [Related]
8. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis. Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941 [TBL] [Abstract][Full Text] [Related]
9. Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria. Rodionova IA; Schuster BM; Guinn KM; Sorci L; Scott DA; Li X; Kheterpal I; Shoen C; Cynamon M; Locher C; Rubin EJ; Osterman AL mBio; 2014 Feb; 5(1):. PubMed ID: 24549842 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential Mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via Virtual High Throughput Screening and Binding free energy studies. Pant R; Joshi A; Maiti P; Nand M; Pande V; Chandra S J Mol Graph Model; 2020 Jul; 98():107584. PubMed ID: 32200279 [TBL] [Abstract][Full Text] [Related]
16. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies. Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990 [TBL] [Abstract][Full Text] [Related]
17. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]